Dendreon

Dendreon

Biotechnology, 1700 Saturn Way, Seal Beach, California, 90740, United States, 501-1000 Employees

dendreon.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 56********

Who is DENDREON

Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreons flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved i...

Read More

map
  • 1700 Saturn Way, Seal Beach , California, 90740, United States Headquarters: 1700 Saturn Way, Seal Beach , California, 90740, United States
  • 1992 Date Founded: 1992
  • 501-1000 Employees: 501-1000
  • dollar-icon Revenue: $250 Million to $500 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from DENDREON

Dendreon Org Chart and Mapping

Employees

Rick Page

Strategic Account Manager

Kevin Helmbacher

SVP of Legal and Compliance and General Counsel

Raul Garcia

Cell Culture Specialst

Lah Donovan

Accounts Payable Supervisor

Elvia Guerrero

Quality Associate II, Document Control

Helen Tran

Total Rewards HRIS Analyst

Judy Yoshida

Senior Manager Sales Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Dendreon

Answer: Dendreon's headquarters are located at 1700 Saturn Way, Seal Beach, California, 90740, United States

Answer: Dendreon's phone number is 56********

Answer: Dendreon's official website is https://dendreon.com

Answer: Dendreon's revenue is $250 Million to $500 Million

Answer: Dendreon's SIC: 2834

Answer: Dendreon's NAICS: 325412

Answer: Dendreon has 501-1000 employees

Answer: Dendreon is in Biotechnology

Answer: Dendreon contact info: Phone number: 56******** Website: https://dendreon.com

Answer: Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreons flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patients own immune cells. More than 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with the hope of curing more men of the disease. Dendreon is headquartered in Seal Beach, Calif.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access